Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS +100.00%*·Rev n/aQ1 26EPS -8.77%·Rev n/aQ4 25EPS +7.59%·Rev n/aQ3 25EPS +40.00%·Rev n/a⚠ consensus missing

Schrodinger, Inc. SDGR

Rob — Operator

Jaren Madden — Chief Corporate Affairs Officer and Head of Investor Relations

Ramy Farid — Chief Executive Officer

Richie Jain — Chief Financial Officer

Karen Akinsanya — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships

+8.6%1d on move date3d+14.5%5d+13.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SDGR calls or request research access.

More SDGR calls Browse calls Request research access